Skip to main content
PHAT logo

PHAT · Phathom Pharmaceuticals, Inc. · Held by Funds

Track PHAT — free
$6.44 +0.45 (+7.46%) Q2 2026 earnings call transcript
Market Cap
$484.60M
Shares
80.90M
Volume · Oct 28 2.08M Avg daily vol (3M) 1.51M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of PHAT by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 10.20% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.26% 1,830,188
Index ETFs 7.94% 6,420,476
Active ETFs 0.41% 329,491
Active funds 11.64% 9,417,528
Unclassified 0.00% 413
All registered funds 22.25% 17,998,096
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding PHAT

165 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 165 positions
Key facts CIK 1783183 CUSIP 71722W107 13F (30d) 19 filings 19 filers Visit website Investor relations